Home › NDC Lookup › Ingredients › Sodium Chloride › 58657-0118-01
Sodium Chloride Normal Salt 1 g Tablet, 100-count — NDC 58657-0118-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Sodium Chloride Normal Salt 1 g Tablet, 100-count — NDC 58657-118-01 (Billing 58657-0118-01)

by Method Pharmaceuticals · 100 TABLET in 1 BOTTLE

This is a package of 100 tablets of Sodium Chloride Normal Salt 1 g Tablet from Method Pharmaceuticals, marketed since Sep 2021 and currently FDA-listed; retail pharmacies pay about $0.0682 per tablet (NADAC). It is this product's only package size.

NDC 58657-0118-01
🏷️ FDA NDC (as labeled) 58657-118-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 58657-118-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
58657 labeler · 118 product · 01 package
Package marketed since
Sep 28, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 5865711801 3
Medicaid fills, this package
5,237 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Sodium Chloride (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class I · Aug 19, 2026 — Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene (B BRAUN MEDICAL INC) · FDA recall D-0869-2026
Class I · Aug 17, 2026 — Presence of particulate matter: Particulates identified as fiberglass (Baxter Healthcare Corporation) · FDA recall D-0849-2026
Class II · Apr 2, 2026 — Lack of Assurance of Sterility (Huons Co., Ltd.) · FDA recall D-0531-2026
Class II · Mar 11, 2026 — Lack of Assurance of Sterility (Fresenius Kabi USA, LLC) · FDA recall D-0427-2026
Class II · Mar 11, 2026 — Lack of Assurance of Sterility (Fresenius Kabi USA, LLC) · FDA recall D-0424-2026
Class II · Mar 11, 2026 — Lack of Assurance of Sterility (Fresenius Kabi USA, LLC) · FDA recall D-0432-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 58657-118-01
Product NDC 58657-118
11-digit billing NDC 58657011801
NCPDP billing unit EA — each (per item)
RxCUI 313009
UNII 451W47IQ8X
Application # M018
SPL Set ID ce84727a-3677-4bf0-e053-2995a90a3ec8
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-09-23
Route ORAL
Dosage form TABLET
Substance SODIUM CHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 79750010000320
GPI class Sodium Chloride
GCN Seq No 060491
GCN 26657
HICL code 000538
Ingredient (HICL) Sodium Chloride
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C1
Therapeutic class — intermediate (HIC2) Drugs Affecting Electrolyte Balance
HIC3 code C1B
Therapeutic class — specific (HIC3) Sodium/Saline Preparations
AHFS code 92:92.00.00
AHFS class Other Miscellaneous Therapeutic Agents
FDB label name SODIUM CHLORIDE 1 GM TABLET
FDB brand name Sodium Chloride
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 060491
  • GCN: 26657
  • GPI-14 (Medi-Span): 79750010000320
  • HICL (First Databank): 000538
  • AHFS class code: 92:92.00.00
  • RxCUI (RxNorm): 313009
Why two NDCs? The FDA registers this code as 58657-118-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 58657-0118-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Sodium class.

Drug family (ATC) Sodium, Salt solutions, Electrolyte solutions
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SODIUM CHLORIDE 1 GM TABLET Ingredient Sodium Chloride
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. IV forms replace fluid and salt, while injection diluents dissolve other drugs. Other forms are used for rinsing, nasal congestion and nasal care, or to...
  • Follow the directions on your product. Many are used as often as needed by adults and children 4 and over. Do not share the bottle, because that can spread infection.
  • Some people get fever, irritation or infection at the IV site, or too much fluid in the body. Tell your nurse right away if the IV site hurts or looks red.
  • What side effects should I expect with IV sodium chloride?
📖 Read our full Sodium Chloride guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.068 $6.82 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.2115 $21.15 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Sep 2023 Jan 2026 May 2026 Sep 2026 $0.069 $0.058
▲ Up 7% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
58657-0118-01 You're viewing this Main listing 100 TABLET in 1 BOTTLE 2021-09-28 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sodium Chloride 1000 mg 57237-0361-01 Rising 100 tablets $0.068 — Availability likely —
Sodium Chloride Normal Salt 1 gthis 58657-0118-01 Method 100 tablets $0.068 — Availability likely —
Sodium Chloride 1000 mg 81033-0028-01 Kesin 100 tablets $0.068 — Availability likely —
Normal Salt 1 g 55681-0305-03 Twin 200 tablets — — FDA listed —
Sodium Chloride Normal Salt 1 g 55681-0333-02 TWIN 200 tablets — — FDA listed —
Sodium Chloride 1 g 58657-0119-01 Method 100 tablets — — FDA listed —
Sodium Chloride Normal Salt 1 g 70369-0007-02 Citragen 500 tablets — — FDA listed —
Normal Salt 1 g 70795-1120-00 GRAXCELL 1000 tablets — — FDA listed —
Sodium Chloride 1 Gram 77333-0835-10 Gendose 100 tablets — — Discontinued —
Sodium Chloride 1 Gram 77333-0844-10 Gendose 100 tablets — — Discontinued —
Sodium Chloride 1 Gram 77333-0846-10 Gendose 1000 tablets — — FDA listed —
Sodium Chloride Normal Salt 1 g 80513-0608-01 Advanced 100 tablets — — FDA listed —
Sodium Chloride 1000 mg 84447-0002-01 Belleview 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Sep 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeRound
ImprintM118
Size12 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Sodium Chloride inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

From the label’s inactive-ingredient sectionNONE

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMethod Pharmaceuticals
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code58657
First marketedSep 2021
Product typeHuman Otc Drug
Portfolio11 products on file

More NDCs from Method Pharmaceuticals labeler code 58657

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 3 words ▾

Indication Electrolyte Replenisher

⏱️ Dosage and Administration 50 words ▾

Directions to make isotonic solutions of sodium chloride, dissolve one tablet in 120 mL (four ounces) of distilled water and use as directed by a physician. if used an electrolyte replinisher for the prevention of heat cramps due to excessive perspiration take one tablet orally as directed by a physician.

⚠️ Warnings 8 words ▾

Warnings Do not use without consulting a physician.

🧪 Active Ingredient 4 words ▾

Active ingredients Sodium Chloride

🧪 Inactive Ingredients 3 words ▾

Inactive Ingredient NONE

🎯 Purpose 33 words ▾

Uses for the normal preparation of isotonic solution of sodium chloride as an electrolyte replinisher for the prevention of heat cramps due to excessive perspiration any alternative use as directed by a physician

📄 Ask a Doctor Before Use If 17 words ▾

Ask a physician before use if you have a sodium restricted diet due to multiple organ disease

📄 Stop Use and Ask a Doctor If 17 words ▾

Stop use and ask a physician if symptoms of heat cramps continue for more than 24 hours.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breastfeeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 3 words ▾

Sodium Chloride sod-chlor

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
5.2K
Units reimbursed last 4 qtrs
364.9K
Gross reimbursed last 4 qtrs
$77.2K
Avg / prescription
$14.74
Avg / unit
$0.2115
Latest quarter Q1 2026
1.5KRx
Medicaid pays / ea
$0.2115
gross reimbursed
vs
NADAC / ea
$0.0682
acquisition cost
=
Spread
+$0.1433
+210% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
50% FFS 50% MCO
Fee-for-service · 2,639 Rx Managed care · 2,598 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 14,907 units · 260 per 100k residents MN Wisconsin: no data reported WI Michigan: 2,412 units · 24.0 per 100k residents MI New York: 37,098 units · 190 per 100k residents NY Vermont: 9,794 units · 1,514 per 100k residents VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: 19,820 units · 621 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 712 units · 5.7 per 100k residents IL Indiana: 2,229 units · 32.5 per 100k residents IN Ohio: 25,326 units · 215 per 100k residents OH Pennsylvania: 8,340 units · 64.3 per 100k residents PA New Jersey: 3,910 units · 42.1 per 100k residents NJ Massachusetts: 6,751 units · 96.4 per 100k residents MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 13,234 units · 292 per 100k residents KY West Virginia: 1,353 units · 76.4 per 100k residents WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 3,579 units · 48.2 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 4,479 units · 83.4 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 210,992 units · 692 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
5.71,514
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Vermont 1,514 /100k
2 Texas 692 /100k
3 Nevada 621 /100k
4 Kentucky 292 /100k
5 Minnesota 260 /100k
6 Ohio 215 /100k
7 New York 190 /100k
8 Massachusetts 96.4 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Sodium Chloride (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Sodium Chloride. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$16.2K
Claims incl. refills
266
Beneficiaries
53
Spend / beneficiary
$304.99
Spend / claim
$60.77
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Sodium chloride — the ingredient across all brands.

Top reported reactions

Fatigue14,416
Nausea14,042
Death13,396
Dyspnoea13,118
Diarrhoea11,836
Headache11,535
Vomiting11,305

Reporter sex

0 reports

Serious outcomes

Hospitalization113,881
Death36,279
Life-threatening17,824
Disabling8,102
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 24,161 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 58633-0704-10 · Dr. 58657-0119-01 · Method →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.